Cargando…
Four‐day plaque regrowth evaluation of a peptide chewing gum in a double‐blind randomized clinical trial
OBJECTIVE: Antimicrobial peptide, KSL‐W, formulated as an antiplaque chewing gum (APCG), was tested to evaluate the dental plaque inhibition activity and safety in an IRB approved and FDA regulated 4‐day plaque regrowth clinical study. METHODS: This Phase 2 two‐armed placebo‐controlled, double blind...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301399/ https://www.ncbi.nlm.nih.gov/pubmed/32558314 http://dx.doi.org/10.1002/cre2.275 |